Stocks · Health care · Pharmaceutical Preparations

Karyopharm Therapeutics Inc.

KPTI Clue Score22

United States Fiscal year ends December CIK 0001503802 Results filed 13 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Garen G Bohlin

12 Sep 2023

Director

Buy

41,140

$1.22

$49.99K

Jatin Shah

7 May 2021

EVP, Chief Medical Officer

Buy

23,250

$8.60

$199.99K

Garen G Bohlin

6 May 2021

Director

Buy

4,000

$7.82

$31.28K

John Demaree

26 Aug 2020

Chief Commercial Officer

Buy

7,500

$14.54

$109.01K

Showing 250 of 393 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 459

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 10

Sales on a Rule 10b5-1 plan 10

Sales straight out of an exercise 161

Sales at will 216

Transactions with no price 0

Shares from compensation/vesting 6,536,376

Sales filed before the plan box existed 119

History held since 13 Nov 2013